Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Operating Expenses | 83,055 | 36,179 | 10,367 |
| Operating Income | -83,055 | -36,179 | -10,367 |
| Interest Expense | 0 | 0 | 285 |
| Other Income | 4,748 | 1,403 | 0 |
| Pre-tax Income | -78,307 | -34,776 | -10,652 |
| Income Tax | N/A | 10 | N/A |
| Net Income Continuous | -78,307 | -34,786 | -10,652 |
| Net Income | $-78,307 | $-34,786 | $-10,652 |
| EPS Basic Total Ops | -3.78 | -23.10 | -13.71 |
| EPS Basic Continuous Ops | -3.78 | -23.10 | -13.71 |
| EPS Diluted Total Ops | -3.78 | -23.10 | -13.71 |
| EPS Diluted Continuous Ops | -3.78 | -23.10 | -13.71 |
| EPS Diluted Before Non-Recurring Items | -3.78 | N/A | N/A |
| EBITDA(a) | $-85,427 | $-36,142 | $-10,352 |